![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 3
Zeitschriftenartikel
de Leval, Laurence; Alizadeh, Ash A.; Bergsagel, P. Leif; Campo, Elias; Davies, Andrew; Dogan, Ahmet; Fitzgibbon, Jude; Horwitz, Steven M.; Melnick, Ari M.; Morice, William G.; Morin, Ryan D.; Nadel, Bertrand; Pileri, Stefano A.; Rosenquist, Richard; Rossi, Davide; Salaverria, Itziar; Steidl, Christian; Treon, Steven P.; Zelenetz, Andrew D.; Advani, Ranjana H.; Allen, Carl E.; Ansell, Stephen M.; Chan, Wing C.; Cook, James R.; Cook, Lucy B.; D'Amore, Francesco; Dirnhofer, Stefan; Dreyling, Martin; Dunleavy, Kieron; Feldman, Andrew L.; Fend, Falko; Gaulard, Philippe; Ghia, Paolo; Gribben, John G.; Hermine, Olivier; Hodson, Daniel J.; Hsi, Eric D.; Inghirami, Giorgio; Jaffe, Elaine S.; Karube, Kennosuke; Kataoka, Keisuke; Klapper, Wolfram; Kim, Won Seog; King, Rebecca L.; Ko, Young H.; LaCasce, Ann S.; Lenz, Georg; Martin-Subero, Jose I.; Piris, Miguel A.; Pittaluga, Stefania; Pasqualucci, Laura; Quintanilla-Martinez, Leticia; Rodig, Scott J.; Rosenwald, Andreas; Salles, Gilles A.; San-Miguel, Jesus; Savage, Kerry J.; Sehn, Laurie H.; Semenzato, Gianpietro; Staudt, Louis M.; Swerdlow, Steven H.; Tam, Constantine S.; Trotman, Judith; Vose, Julie M.; Weigert, Oliver; Wilson, Wyndham H.; Winter, Jane N.; Wu, Catherine J.; Zinzani, Pier L.; Zucca, Emanuele; Bagg, Adam und Scott, David W.
(2022):
Genomic profiling for clinical decision making in lymphoid neoplasms.
In: Blood, Bd. 140, Nr. 21: S. 2193-2227
Mondello, Patrizia; Tadros, Saber; Teater, Matt; Fontan, Lorena; Chang, Aaron Y.; Jain, Neeraj; Yang, Haopeng; Singh, Shailbala; Ying, Hsia-Yuan; Chu, Chi-Shuen; Ma, Man Chun John; Toska, Eneda; Alig, Stefan; Durant, Matthew; de Stanchina, Elisa; Ghosh, Sreejoyee; Mottok, Anja; Nastoupil, Loretta; Neelapu, Sattva S.; Weigert, Oliver; Inghirami, Giorgio; Baselga, Jose; Younes, Anas; Yee, Cassian; Dogan, Ahmet; Scheinberg, David A.; Roeder, Robert G.; Melnick, Ari M. und Green, Michael R.
(2020):
Selective Inhibition of HDAC3 Targets Synthetic Vulnerabilities and Activates Immune Surveillance in Lymphoma.
In: Cancer Discovery, Bd. 10, Nr. 3: S. 440-459
Townsend, Elizabeth C.; Murakami, Mark A.; Christodoulou, Alexandra; Christie, Amanda L.; Köster, Johannes; DeSouza, Tiffany A.; Morgan, Elizabeth A.; Kallgren, Scott P.; Liu, Huiyun; Wu, Shuo-Chieh; Plana, Olivia; Montero, Joan; Stevenson, Kristen E.; Rao, Prakash; Vadhi, Raga; Andreeff, Michael; Armand, Philippe; Ballen, Karen K.; Barzaghi-Rinaudo, Patrizia; Cahill, Sarah; Clark, Rachael A.; Cooke, Vesselina G.; Davids, Matthew S.; DeAngelo, Daniel J.; Dorfman, David M.; Eaton, Hilary; Ebert, Benjamin L.; Etchin, Julia; Firestone, Brant; Fisher, David C.; Freedman, Arnold S.; Galinsky, Ilene A.; Gao, Hui; Garcia, Jacqueline S.; Garnache-Ottou, Francine; Graubert, Timothy A.; Gutierrez, Alejandro; Halilovic, Ensar; Harris, Marian H.; Herbert, Zachary T.; Horwitz, Steven M.; Inghirami, Giorgio; Intlekoffer, Andrew M.; Ito, Moriko; Izraeli, Shai; Jacobsen, Eric D.; Jacobson, Caron A.; Jeay, Sebastien; Jeremias, Irmela; Kelliher, Michelle A.; Koch, Raphael; Konopleva, Marina; Kopp, Nadja; Kornblau, Steven M.; Kung, Andrew L.; Kupper, Thomas S.; LaBoeuf, Nicole; LaCasce, Ann S.; Lees, Emma; Li, Loretta S.; Look, A. Thomas; Murakami, Masato; Muschen, Markus; Neuberg, Donna; Ng, Samuel Y.; Odejide, Oreofe O.; Orkin, Stuart H.; Paquette, Rachel R.; Place, Andrew E.; Roderick, Justine E.; Ryan, Jeremy A.; Sallan, Stephen E.; Shoji, Brent; Silverman, Lewis B.; Soiffer, Robert J.; Steensma, David P.; Stegmaier, Kimberly; Stone, Richard M.; Tamburini, Jerome; Thorner, Aaron R.; Hummelen, Paul van; Wadleigh, Martha; Wiesmann, Marion; Weng, Andrew P.; Wuerthner, Jens U.; Williams, David A.; Wollison, Bruce M.; Lane, Andrew A.; Letai, Anthony; Bertagnolli, Monica M.; Ritz, Jerome; Brown, Myles; Long, Henry; Aster, Jon C.; Shipp, Margaret A.; Griffin, James D. und Weinstock, David M.
(2016):
The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice.
In: Cancer Cell, Bd. 29, Nr. 4: S. 574-586